J. Besalduch

发表

Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patients

J. San-Miguel, J. Bladé, J. Lahuerta, 2000, British journal of haematology.

Treatment practices in adults with chronic immune thrombocytopenia – a European perspective

F. Rodeghiero, M. Michel, D. Provan, 2010, European journal of haematology.

Alternating combination VCMP/VBAP chemotherapy versus melphalan/prednisone in the treatment of multiple myeloma: a randomized multicentric study of 487 patients.

J. Garcia-conde, M. Sanz, J. Maldonado, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized multicentric study comparing alternating combination chemotherapy (VCMP/VBAP) and melphalan-prednisone in multiple myeloma

J. Garcia-conde, J. Maldonado, J. S. San Miguel, 1990, Blut.

Maintenance treatment with interferon alpha-2b in multiple myeloma: a prospective randomized study from PETHEMA (Program for the Study and Treatment of Hematological Malignancies, Spanish Society of Hematology)

E. Montserrat, J. Garcia-conde, J. Bladé, 1998, Leukemia.

Rapid triplex asymmetric real-time PCR hybridization probe assay for the joint genotyping of F2, F5 and F12.

A. Gutiérrez, J. Martínez-Serra, T. Ros, 2009, Clinical biochemistry.

Thalidomide/Dexamethasone (TD) Vs. Bortezomib(Velcade®)/Thalidomide/Dexamethasone (VTD) Vs. VBMCP/VBAD/Velcade® As Induction Regimens Prior Autologous Stem Cell Transplantation (ASCT) in Younger Patients with Multiple Myeloma (MM): First Results of a Prospective Phase III PETHEMA/Gem Trial

M. Terol, J. Miguel, A. Oriol, 2008 .

Are myeloma patients with renal failure candidates for autologous stem cell transplantation?

C. Solano, J. Maldonado, J. S. San Miguel, 2000, The hematology journal : the official journal of the European Haematology Association.

Efficacy and Effectiveness of Azacitidine In Elderly Patients with Acute Myeloid Leukemia and Blasts Counts below 30%: Experience of the Spanish Registry

J. Bargay, E. Luño, J. Besalduch, 2010 .

A randomized trial comparing chlorambucil plus prednisone vs cyclophosphamide, melphalan, and prednisone in the treatment of chronic lymphocytic leukemia stages B and C.

E. Montserrat, J. Garcia-conde, J. Moraleda, 1988, Nouvelle revue francaise d'hematologie.

Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.

L. Kappos, E. Havrdová, A. Steck, 2002, Journal of neurology.

Thalidomide / Dexamethasone (TD) Vs. Bortezomib (Velcade)â/Thalidomide / Dexamethasone (VTD) Vs. VBMCP/VBAD/Velcadeâ as Induction Regimens Prior Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM): Results of a Phase III PETHEMA/GEM Trial.

M. Terol, J. Miguel, A. Oriol, 2009 .

Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry

C. Solano, S. Brunet, F. Hernández-Navarro, 1998, Bone Marrow Transplantation.

A Phase III PETHEMA/GEM Study of Induction Therapy Prior Autologous Stem Cell Transplantation (ASCT) In Multiple Myeloma: Superiority of VTD (Bortezomib/Thalidomide/Dexamethasone) Over TD and VBMCP/VBAD Plus Bortezomib

J. Miguel, A. Oriol, J. Bladé, 2010 .

A PETHEMA study of high-dose therapy/stem cell support (HDT), including tandem transplant, in primary refractory multiple myeloma (MM): Identification of two populations with different outcomes

J. Bladé, J. Lahuerta, R. García-Sanz, 2007 .

Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination

M. Sanz, J. Sanz, L. Madero, 2012, Mediterranean journal of hematology and infectious diseases.

Outcome of Antifungal Combination Therapy Hematological Patients is Independent

M. Sanz, J. Sanz, L. Madero, 2012 .

Hematopoietic stem cell transplantation for multiple sclerosis

L. Kappos, E. Havrdová, A. Steck, 2002, Journal of Neurology.

Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse.

J. Garcia-conde, P. Torres, J. Rifón, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Autologous stem cell transplantation for systemic lupus erythematosus

P. Emery, A. Gratwohl, F. Zintl, 2004, Lupus.

Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patients.

J. Esteve, E. Montserrat, J. Garcia-conde, 2001, The hematology journal : the official journal of the European Haematology Association.

Combination Chemotherapy with Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) Induces a High Response Rate in Previously Untreated CLL.

E. Giné, F. Bosch, E. Montserrat, 2005 .

Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database

E. Havrdová, R. Clark, A. Steck, 2006, Multiple sclerosis.

Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials

A. Oriol, N. Gutiérrez, B. Paiva, 2018, PloS one.

Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study*

G. Nocea, M. Sanz, M. Rovira, 2005, Current medical research and opinion.

Gemcitabine and Oxaliplatinum (GemOx): An Effective Regimen in Patients with Refractory and Relapsing Hodgkin Lymphoma

P. Galan, J. Rodríguez, J. Bargay, 2012 .

Maintenance Therapy After Stem-Cell Transplantation for Multiple Myeloma with Bortezomib/Thalidomide Vs. Thalidomide Vs. alfa2b-Interferon: Final Results of a Phase III Pethema/GEM Randomized Trial

J. Miguel, A. Oriol, J. Bladé, 2012 .

CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy

J. Esteve, M. Tormo, J. Besalduch, 2009, Leukemia.

Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA.

C. Solano, S. Brunet, F. Hernández-Navarro, 1998, Bone Marrow Transplantation.

Elliptopoikilocytosis associated with the alpha 469 His-->Pro mutation in spectrin Barcelona (alpha I/50-46b).

M. Aymerich, L. Denoroy, J. Delaunay, 1993, Blood.

Autologous stem cell transplantation for systemic lupus erythematosus

L. Fouillard, A. Tyndall, D. Jayne, 2004, Lupus.

Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.

J. Garcia-conde, J. Hernández-Rivas, A. Oriol, 1998, Haematologica.

Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89)

A. Oriol, E. Feliú, M. Fontanillas, 1998 .